General Office of the General Administration of the people's Republic of China solicits public opinions on the quality management standard for clinical trials of drugs (Revised Version)
-
Last Update: 2016-12-05
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Source: CFDA 2016-12-5 in order to improve the quality of drug clinical research, the State Food and Drug Administration revised the quality management specification for drug clinical trials (Order No 3 of the former State Food and Drug Administration), drafted the quality management specification for drug clinical trials (Revised Draft), and now solicited opinions from the public Please send relevant comments to the drug and cosmetic registration department of the State Food and drug administration by email before January 31, 2017 Contact person: Xie xingyong email: xiexy@cfda.gov.cn Annex: drug clinical trial quality management specification (Revised Version) General Office of food and Drug Administration December 1, 2016 Annex: drug clinical trial quality management specification (Revised Version) Docx
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
